STAA News and Press, STAAR Surgical Company From 12/09/25

Notes That Price Bump Is Further Evidence That the Original Sale Process Was Horribly Flawed and Failed to Maximize Shareholder Value New Price Is Approximately Half the Price Offered by Alcon Twice in 2024; STAAR’s Projections Have Not Changed Materially Continues to Urge ...

2025-12-09 09:06:59 ET More on STAAR Surgical, Alcon Alcon: Some Premium Coming Out Of This Quality Play Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript Alcon Inc. 2025 Q3 - Results - Earnings Call Presentation STAAR Surgical says no offers received during ...

Agreement follows discussions with STAAR stockholders and the closure of STAAR’s “go-shop” period New terms include an increase in acquisition price and reductions in payments to executives Alcon urges STAAR stockholders to vote in favor of the transaction in ...

Believes Belated Go-Shop Process Fails to Cure Fundamental Flaws in the Transaction’s Process, Timing, and Price Expresses Disappointment that the Self-Interested and Conflicted Board Members Continue to Press Forward with a Transaction that Shareholders Have Already Roundly Reject...

2025-12-08 09:11:34 ET More on STAAR Surgical Broadwood pushes for removal of 3 STAAR Surgical board members (update) STAAR Surgical adds 30-day go-shop to Alcon transaction Seeking Alpha’s Quant Rating on STAAR Surgical Historical earnings data for ST...

Egan-Jones Takes No Comfort From Perfunctory Go-Shop Process and Says Concerns Regarding Objectivity and Fairness Remain the Same Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that leading proxy advisory firm Egan-Jones Ratings...

No Competing Acquisition Proposals Received Results of Go-Shop Process Validate the Effectiveness of the STAAR Board’s Process Now is the Right Time to Sell the Business and Alcon is the Right Buyer STAAR Surgical Company (NASDAQ: STAA), the global leader in pha...

2025-12-02 17:03:04 ET More on STAAR Surgical, Alcon Alcon: Some Premium Coming Out Of This Quality Play Alcon Inc. (ALC) Q3 2025 Earnings Call Transcript Alcon Inc. 2025 Q3 - Results - Earnings Call Presentation Alcon reaffirms $10.3B–$10.4B 2025 sale...

Pursuing Board Changes to Restore Investor Confidence and Ensure Integrity of Ongoing Sale Process Broadwood Seeks to Remove the Directors Most Responsible for the Flawed Sale Process: Board Chair Elizabeth Yeu, CEO Stephen Farrell, and Compensation Committee Chair Arthur Butcher ...

2025-11-14 18:13:02 ET In August, I believed that there were more than meets the eye in case of Alcon Inc. ( ALC ). The undoubted leader in eye care enjoys a strong and diversified positioning, benefiting from tailwinds related to aging populations and technological advances...